Nutrition and apoptosis

Nutrition Research

Volumn 16, Issue 11-12, 1996, Pages 1959-1987

  Troyer, Dean ^a   Fernandes, Gabriel ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE   (United States)

Author keywords

apoptosis; lipids; nutrition; omega 3 fatty acids

Indexed keywords

CORTICOSTERONE; CYTOKINE; GLUCOCORTICOID; OMEGA 3 FATTY ACID; PROTEIN P53;

AGING; APOPTOSIS; AUTOIMMUNITY; CALORIC RESTRICTION; CARCINOGENESIS; HUMAN; IMMUNE SYSTEM; LIFESPAN; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0030296997     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(96)00219-9     Document Type: Review

References (176)

1. 1. Fernandes G. Nutritional factors: Modulating effects on immune function and aging. Pharmacol Revs 1984; 36:123S-129S.
2. 2. Weindruch R. Retardation of aging by caloric restriction in mice. In: Ingram DK, Baker III GT, Shock NW, Eds. The Potential For Nutritional Modulation of Aging Process. Vol. Trumbull, CT: Food & Nutrition Press, Inc. 1991: 109-122.
3. 3. Weindruch R. Effect of calorie restriction on age-associated cancers. Exp Gerontol 1992; 27:575-581.
4. 4. Fernandes G. Dietary lipids and risk of autoimmune disease. Clin Immunol Immunopath 1994; 72:193-197.
5. 5. Fernandes G. Effect of calorie restriction and omega-3 fatty acids on autoimmunity and aging. Nutr Rev 1995; 53:S72-S79.
6. 6. Wang E, Lee MJ. Control of fibroblast senescence and activation of programmed cell death. J Cell Biochem 1994; 54:432-439.
7. 7. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl-2 is involved. Cancer Res 1995; 55:2284-2292.
8. 8. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44:817-829.
9. 9. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
10. 10. Masoro EJ. Biology of aging: Facts, thoughts, and experimental approaches. Lab Invest 1991; 65:500-510.
11. 11. Warner HR, Fernandes G, Wang E. A unifying hypothesis to explain the retardation of aging and tumorigenesis by caloric restriction. J Gerontol 1995; 50A:B107-B109.
12. 12. Yu BP, Lee DW, Marler CG, Choi J-H. Mechanisms of food restriction: Protection of cellular homeostasis. Proc Soc Exp Biol Med 1990; 193:13-15.
13. 13. Hamada N, Engelman RW, Tomita Y, Chen RF, Iwai H, Good RA, Day NK. Prolactin effects on the dietary regulation of mouse mammary tumor proviral DNA expression. Proc Natl Acad Sci USA 1990; 87:6733-6737.
14. 14. Nelson JF. The potential role of endocrine systems in the retardation of aging by caloric restriction. Age Nutr 1992; 3:171-178.
15. 15. Egerton M, Scollary R, Shortman K. Kinetics of mature T-cell development in the thymus. Proc Natl Acad Sci USA 1990; 87:2579.
16. 16. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
17. 17. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus, occurrence as multimeric complexes bound to histone. J Clin Invest 1990; 86:69-74.
18. 18. Elkon KB. Apoptosis and SLE - too little or too much? Lupus 1994; 3:1-2.
19. 19. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152:3685-3692.
20. 20. Savill J, Fadok V, Henson P, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunology Today 1993; 14:131-136.
21. 21. Kerr JFR. Neglected opportunities in apoptosis research. Trends Cell Biol 1995; 5:55-57.
22. 22. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148:2207-2216.
23. 23. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature 1980; 284:555-556.
24. 24. Luan X, Zhao W, Chandrasekar B, Fernandes G. Calorie restriction modulates lymphocyte subset phenotype and increases apoptosis in MRL/lpr mice. Immunol Lett 1995; 47:181-186.
25. 25. Bortner CD, Oldenburg NBE, Cidlowski JA. The role of DNA fragmentation in apoptosis. Trends Cell Biol 1995; 5:21-26.
26. 26. Gavreli Y, Sherman B, Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
27. 27. Darzyn-Kiewicz Z, Bruno S, Del Bino G, Gorzyca W, Holz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13:795-808.
28. 28. Telford WG, King LE, Fraker PJ. Rapid quantitation of apopotsis in pure and heterogeneous cell populations using flow cytometery. J Immunol Methods 1994; 172:1-16.
29. 29. Li X, Traganos F, Malamed MR, Darzyn-Kiewicz Z,. Single step procedure for labeling DNA strand breaks with fluorescein-or BODIPY-conjugated deoxynucleotides: Detection of apoptosis and bromodeoxy uridine incorporation. Cytometry 1995.
30. 30. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267:1445-1449.
31. 31. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science 1993; 262:695.
32. 32. Arenas MJ, McGregor AH, Toft NJ, Brown EJ, Wyllie AH. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 1993; 68:1127-1133.
33. 33. Hockenberry D, Nuñez G, Milliman C, Schreiber D, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348:334-336.
34. 34. Ishizaki Y, Cheng L, Mudge AW, Raff MC. Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol 1995; 6:1443-1458.
35. 35. Martin SJ, Green DR. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995; 82:349-352.
36. 36. Ellis RE, Yuan J, Horvitz RH. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7:663-698.
37. 37. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA. Molecular cloning of the interleukin-1b converting enzyme. Science 1992; 256:97-100.
38. 38. White K, Grether ME, Abrans JM, Young L, Farrell K, Steller H. Genetic control of programmed cell death in Drosophila. Science 1994; 264:677-683.
39. 39. Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that Induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992; 176:11521-1529.
40. 40. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76:977-987.
41. 41. Glucksmann A. Cell death in normal vertebrate ontogeny. Biol Revs 1951; 26:59.
42. 42. Jacobson MD, Burne JF, Faff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO 1994; 13:1899-1910.
43. 43. Nagata S, Golstein P. The Fas death factor. Science 1995; 267:1449-1456.
44. 44. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw W. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 1993; 123:7-22.
45. 45. Newmeyer D, Farschon DM, Reed J. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994; 79:353-364.
46. 46. Duke RC, Cohen JJ. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 1986; 139:3199-3206.
47. 47. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Ann Rev Immunol 1992; 10:267-293.
48. 48. Sellins K, Cohen J. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J of Immunol 1987; 139:3199-3206.
49. 49. McConkey DJ, Hartzell P, Duddy SK, Hakansson H, Orrenius S. 2,3,7,8-Tetracholodibenzo-p-dioxin kills immature thymocytes by Ca++-mediated endonuclease activation. Science 1988; 242:256-259.
50. 50. McConkey DJ, Orrenius S. Signal transduction pathways to apoptosis. Trends Cell Biol 1994; 4:370-375.
51. 51. Kolesnick RN. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apopptosis. J Exp Med 1994; 180:525-535
52. 52. Hamiovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McL:oughlin M, Fuks Z, Kolesnick RN. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180:525-535.
53. 53. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259:1769-1771.
54. 54. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82:405-414.
55. 55. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular iymphoma. Science. 1985; 1440-1443.
56. 56. Korsmeyer S. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80:879-886.
57. 57. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142:743-753.
58. 58. Gratiot-Deans J, Dig L, Turka LA, Turka LA, Nunez GJ. Bcl-2 proto-oncogene expression during human T cell development. Immunol 1993; 151:83-91.
59. 59. Veis D, Sorenson C, Shutter J, Korsmeyer S. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75:229-240.
60. 60. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349:254-256.
61. 61. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arth Rheum 1994; 37:1423-1430.
62. 62. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD. Protection of fasmediated apoptosis by a soluble form of the fas molecule. Science 1994; 263:1759-1762.
63. 63. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145:1323-1336.
64. 64. Nunez G, Clarke MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 1994; 4:399-403.
65. 65. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362:847-849.
66. 66. Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993; 90:5742-5746.
67. 67. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol 1994; 6:1567-1574.
68. 68. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 1994; 76:959-962.
69. 69. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transportable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993; 90:1756-1761.
70. 70. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993; 178:461-468.
71. 71. Chu J-L, Drappa J, Parnassa A, B. EK. Thje defect of fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn J Exp Med 1993; 178:723-730.
72. 72. Wu J, Zhou T, Zhang J, He J, Gause WC, Mountz JD. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci USA 1994; 91:2344-2348.
73. 73. Cohen PL, Eisenberg RA. Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9:243-269.
74. 74. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 1994; 76:969-976.
75. 75. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75:1169-1178.
76. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177:195-200.
77. 77. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148:1274-1279.
78. 78. Doll R, Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66:1191-1309.
79. 79. Heber D, McCarthy WJ, Ashley J, Byerley LO. Weight reduction for breast cancer prevention by restriction of dietary fat and calories: Rationale, mechanisms and intervention. Nutr 1989; 5:149-154.
80. 80. Henderson MM. NO TITLE. Cancer Res (Suppl) 1992; 52:2030s-2034s.
81. 81. Willett WC, Stampfer MJ, Golditz GA, Rosner BA, Speizer FE. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323:1664-1672.
82. 82. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-2026.
83. 83. Grasl-Krauppk B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B, Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Nat Acad Sci USA 1994; 91:9995-9999.
84. 84. James SJ, Muskhelishvili L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6xC3H F1 mice. Cancer Res 1994; 54:5508-5510.
85. 85. Klas C, Debatin KM, Jonker RR, Krammer PH. Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 1993; 5:625-630.
86. 86. Weindruch R, Walford R. The Retardation Of Aging And Disease By Dietary Restriction, Springfield, IL: Charles C. Thomas, 1988:436.
87. 87. Weindruch R, Walford RL, Fligiel S, Guthrie D. The retardation of aging in mice by dietary restriction: Longevity, cancer, immunity and lifetime energy intake. J Nutr 1986; 116:641-654.
88. 88. Walford RL. Models for investigating how dietary restriction retards aging: The adaptation hypothesis. In: Fishbein L, Eds. Biological Effects of Dietary Restriction Vol. Berlin, Germany Springer-Verlag, 1991:229-237.
89. 89. Sacher GA. Theories in gerontology: Part I. In: Eisdorfer C, Eds. Annual Review of Gerontology and Geriatrics Vol. 1 New York: Springer-Verlag, 1980:3-25.
90. 90. Masoro E. Overview of the effects of food restriction. In: Snyder DL, Eds. Dietary Restriction And Aging Vol. New York, NY: Alan R. Liss, Inc., 1989:27-35.
91. 91. Masoro EJ, Yu BP. Editorial: Diet and nephropathy. Lab Invest 1989; 60:165-167.
92. 92. Rous P. The influence of diet on transplanted and spontaneous mouse tumors. J Exp Med 1914; 20:433-451.
93. 93. Fernandes G, Chandrasekar B, Troyer DA, Venkatraman JT, Good RA. Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 1995; 92:6494-6498.
94. 94. Oren M. p53: The ultimate tumor suppressor gene? FASEB J 1992; 6:3169-3176.
95. 95. Lane DP. p53 guardian of the genome. Nature 1992; 358:15-16.
96. 96. Engelman RW, Day N, Good RA. Calories, parity and prolactin influence mammary epithelial kinetics and differentiation and alter mouse mammary tumor risk. Cancer Res 1993; 53:1188-1194.
97. 97. Wyllie AH. Apoptosis. Br J Cancer 1993; 67:205-208.
98. 98. Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptostic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 552-554.
99. 99. Shay J. Aging and cancer: Are telomeres and telomerase the connection? Mole Med Today 1995; 1:378-384.
100. 100. Kondo Y, Homma Y, Aso Y, Kakizoe T. Promotional effect of two-generation exposure toa high-fat diet on prostate carcinogenesis in aCI/Seg rats. Cancer Res 1994; 23:6129-6132.
101. 101. Barker DJP. The intrauterine origins of cardiovascular and obstructive lung disease in adult life. J Royal Coll Phys of London 1991; 25:129-133.
102. 102. Barker DJP. The fetal and infant origins of disease. Euro J Clin Invest 1995; 25:457-463.
103. 103. McCay CM, Crowelt MF, Maynard LA. The effect of retarded growth upon the length of the life span and upon the ultimate body size. J Nutr 1935; 10:63-79.
104. 104. Man-Fan Wan J, Kanders B, Kowackuk M, Knapp H, Szeluga dJ, Bagley J, Blackburn GL. ω-3 fatty acids and cancer metastasis in humans. World Rev Nutr & Dietet 1991; 66:477-487.
105. 105. Fernandes G, Venkatraman JT. Possible mechanisms through which dietary lipids and calorie restriction modulate the growth of breast cancer. In: Jacobs MM, Eds. Exercise, Calories, Fat and Cancer Vol. 322 Washington, DC: Plenum Press, 1992:185-201.
106. 106. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune disease: A problem of defective apoptosis. Arth Rheumat 1994; 37:1415-1420.
107. 107. Ogawa N, Dang H, Talal N. Apoptosis and autoimmunity. J Autoimmunity 1995; 8:1-20.
108. 108. Tomei LD, Cope FO, Barr PJ. Apoptosis: Aging and phenotypic fidelity. In: Tomei LD, Cope FO, Eds. Apoptosis II. The Molecular Basis Of Apoptosis In Disease Vol. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994: 377-396.
109. 109. Feuers RJ, Weindruch R, Hart RW. Calorie restriction, aging and antioxidant enzymes. Mutation Res 1993; 295:191-200.
110. 110. Harman D. Free radical theory of aging: Role of free radicals in the origination and evolution of life, aging, and disease processes. In: Johnson Jr. JE, Walford R, Harman D, Miquel J, Eds. Free Radicals, Aging and Degenerative Disease. Vol. New York, NY: Liss, 1986: 3-49.
111. 111. Wolfe JT, Ross D, Cohen GM. A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Letts 1994; 352:58-62.
112. 112. Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis ine mbryonic cortical neurons. J Neurochem 1994; 62:376-379.
113. 113. Forrest VJ, Kang YH, McClain DE, Robinson DH, Ramakrishnan N. Oxidative stress-induced apoptosis prevented by trolox. Free Radical Biol and Med 1994; 16:675-684.
114. 114. Buttke T, Sandstrom P. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15:7-10.
115. 115. Kane DJ, Sarafian T, Anton R, Hahn H, Gralla E, Balentine J, Ord T, Bredesen D. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262:1274-1277.
116. 116. Abello PA, Fidler SA, Bulkley GB, Buchman TG. Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg 1994; 129:134-141.
117. 117. Troy CM, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptosic death in PC12 neuronal cells. Proc Natl Acad Sci USA 1994; 91:6384-6387.
118. 118. Hockenberry DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75:241-251.
119. 119. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361:365-369.
120. 120. Hensler PJ, Pereira-Smith OM. Human replicative senescence: A molecular study. Am J Path 1995; 147:1-8.
121. 121. Fernandes G, Venkatraman JT. Dietary restriction: Effect on immunological function and aging. In: Klurfeld DM, Eds. Human Nutrition: A Comprehensive Treatise. Vol. 8 New York, NY: Plenum Press, 1993:91-120.
122. 122. Fernandes G, Yunis EJ, Good RA. Influence of diet on survival of mice. Proc Natl Acad Sci USA 1976; 73:1276-1283.
123. 1 mice. Proc Natl Acad Sci USA 1978; 75:1500-1504.
124. 124. Fernandes G, Chandrasekar B, Luan X, Troyer DA. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids 1996; 31:S92-S96
125. 125. Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. Ann NY Acad Sci 1992; 663:85-96.
126. 126. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 37:585-621.
127. 127. Harley CB, Vaziri H, Counter C, Allsopp RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27:375-382.
128. 128. Olovnikov AM. A theory of marginotomy. J Theor Biol 1973; 41:181-190.
129. 129. Sabatini F, Masoro E, McMahan CA, Kuhn RW. Assessment of the role of the glucocorticoid system in aging processes in the action of food restriction. J Gerontol Biol Sci 1991; 46:8171-B179.
130. 130. Nelson JF. Neuroendocrine involvement int he retadation of aging by dietary restriction: A hypothesis. In: Yu BP, Eds. Modulation by Diet Restriction. Vol. Boca Raton, FL: CRC Press, 1994.
131. 131. Oka S, Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of gene expression. J Biol Chem 1991; 266:9956-9960.
132. 132. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: The giucocorticoid cascade hypothesis. Endocrin Rev 1986; 7:284-301.
133. 133. Klebanov S, Dia S, Stavinoha W, Suh Y, Nelson J. Hyperadrenocorticism, attenuated inflammation, and life-prolonging action of food restriction in mice. J Gerontol 1995; 50A:B78-82.
134. 134. Stewart J, Meaney MJ, Aitken D, Jensen L, Kalant N. The effects of acute and life-long food restriction onbasal and stress-induced serum corticosterone levels in young and aged rats. Endocrinol 1988; 123:1934-1941.
135. 135. Fernandes G, Halberg F, Halberg E, Miranda M, Yunis EJ, Good RA. Murine circadian rhythm in natural cell-mediated cytotoxicity against lymphoma cells and chronoimmunology. In: CA W, Eds. International Symposium on Clinical Chronopharmacy, Chronopharmacology and Chronotherapeutics Vol. 1981: 233-246.
136. 136. Fernandes G, Yunis EJ, Halberg F. Circadian aspects of immune responses in the mouse. In: McGovern JP, Smolensky MH, Reinberg A, Eds. Chronobiology in Allergy and Immunology Vol. Springfield, IL: Charles C Thomas, Inc., 1977: 233-249.
137. 137. Goodgame JT, Lowry SF, Reilly JJ, Jones DC, Brennan MF. Nutritional manipulations and tumor growth I. The effects of starvation. Am J Clin Nutrition 1979; 32:2277-2284.
138. 138. Laconi E, Tessitore L, Milia G, Yusuf A, Sarma DSR, Todde P, Pani P. The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis 1995; 16:1865-1869.
139. 139. Mehta RS, Harris SR, Gunnett CA, Bunce OR, Hartle DK. The effect of patterned calorie-restricted diets on mammary tumor incidence and plasma endothelin levels in DMBA-treated rats. Carcinogenesis 1993; 14:1693-1696.
140. 140. Illera V, Perandones CE, Stunz LL, Mower DA Jr., Ashman RF. Apoptosis in-splenic B lymphocytes. J Immunol 1993; 151:2965-2973.
141. 141. Van Eekelen JAM, Oitzl MS, De Kloet ER. Adrenocortical hyporesponsiveness and glucocorticoid feedback resistance in old male brown Norway rats. J Gerontol 1995; 50A:B83-B89.
142. 142. Gruber J, Roswitha S, Hu YH, Beug H, Wick G. Thymocyte apoptosis induced by elevated endogenous corticosteroid levels. Eur J Immunol 1994; 24:1115-1121.
143. 143. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132:38-42.
144. 144. Perandones C, Illera V, Peckham D, Stunz L, Ashman R. Regulation of apoptosis in vitro in mature murine spleen T cells. J of Immunol 1993; 151:3521-3529.
145. 145. Depasquale-Jardieu P, Fraker PJ. Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J Immunol 1980; 124:2650-2655.
146. 146. Fernandes G, Yunis EJ, Good RA. Depression of cytotoxic T cell subpopulation in mice by hydrocortisone treatment. Clin Immunol Immunopathol 1975; 4:303-314.
147. 147. Garvy BA, King LE, Telford WG, Morford LA, Fraker PJ. Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunol 1993; 80:587-592.
148. 148. Inomata T, Nakamura T. Influence of adrenalectomy on the development of the neonatal thymus in the rat. Biol Neonate 1989; 55:238-247.
149. 149. Vacchio M, Papadapoulos V, Ashwell JD. Steroid production in the thymus: Implications foir thymocyte selection. J Exp Med 1994; 179:1835-1846.
150. 150. Marin-Fontecha A, Broekhuizen R, Heer CD, Zapata A, Shchuurman HJ. The neuro-endocrine component of the rat thymus: Studies on cultured thymic fragments before and after transplantation in congenially athymic and euthymic rats. Brain Behv Immunol 1993; 7:1-15.
151. 151. Ashton-Rickardt PG, Bnadeira A, Delaney JR, Kaer LV, Pircher HP, Zinkernagel RM, Tonegawa S. Evidence of a differential avidity model of T cell selection in the thymus. Cell 1994; 76:651-663.
152. 152. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13:307-338.
153. 153. Jameson SC, Hogquist KA, Bevan MJ. Positive selection of thymocytes. Annu Rev Immunol 1995; 13:93-126.
154. 154. Li YM, Brunke DL, Dantzer R, Kelly KW. Pituitary epithelial cell implants reverse the accumulation of CD4-CD8-lymphocytes in thymus glands of aged rats. Endocrinol 1992; 130:2703-2709.
155. 155. Chung OK, Pomeranz Y. Recent trends in usage of fats and oils as functional ingredients in the baking industry. JAOCS 1983; 60:1848-1851.
156. 156. Hunter J, Applewhite T. Isomeric fatty acids in the US diet: Levels and health perspectives. Am J Clin Nutr 1986; 44:707-717.
157. 157. Eaton SB. Humans, lipids and evolution. Lipids 1992; 27:814-820.
158. 158. Willett W. Diet and health: What should we eat? Science 1994; 264:532-537.
159. 159. Enig MG, Pallansch LA, Sampugna J, Keeney M. Fatty acid composition of the fat in selected food items with emphasis on trans components. JAOCS 1983; 60:1788-1795.
160. 160. Byun DS, Venkatraman JT, Yu BP, Fernandes G. Modulation of antioxidant activities and immune response by food restriction in aging Fischer-344 rats. Aging Clin Exp Res 1995; 7:40-48.
161. 161. Venkatraman J, Fernandes, G. Mechanisms of delayed autoimmune disease in B/W mice by n-3 lipids and food restriction. Nutrition and Immunology 1991; 309-323.
162. 162. Laganiere S, Fernandes G. Study on the lipid composition of aging Fischer-344 rat lymphoid cells: Effect of long-term calorie restriction. Lipids 1991; 26:472-478.
163. 163. Welsch CW. Relationship between dietary fat and experimental mammary tumorigenesis: A Review and Critique. Cancer Res (Suppl) 1992; 52:2040s-2048s.
164. 164. Pollard M, Luckert PH. Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 1986; 32:223-227.
165. 165. Laganiere S, Yu BP, Fernandes G. Studies on membrane lipid peroxidation in n-3 fatty acid-fed autoimmune mice: Effect of vitamin E supplementation. In: Bendich A, Phillips M, Tengerdy RB, Eds. Antioxidant Nutrients And Immune Functions. Vol. 262 New York, NY: Plenum Press, 1989. 95-102.
166. 166. NIH Library of Medicine. Effects of fish oil and polyunsaturated omeg-3 fatty acids in health and disease. Special bibliography 1995; 1-50.
167. 167. Sardesai VM. Nutritional role of polyunsaturated fatty acids. J Nutr Biochem 1992; 3:154-165.
168. 168. Sardesai VM. Biochemical and nutritional aspects of eicosanoids. J Nutr Biochem 1992; 3:562-579.
169. 1 mice. Lipids 1994; 29:561-567.
170. 170. Clarke SD, Jump DB. Dietary polyunsaturated fatty acid regulation of gene transcription. Annu Rev Nutr 1994; 14:83-98.
171. 171. Finstad HS, Kolset SO, Holme JA, Wiger R, Farrants AK, Bonhoff R, Drevon CA. Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells Blood 1994; 84:3799-3809.
172. 172. Grimaldi PA, Knobel SM, Whitsell RR, Abumrad NA. Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci USA 1992; 89:10930-10934.
173. 173. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12,14-prostaglandin J2 is a lignad for the adipocyte determination factor PPARg. Cell 1995; 83:803-812.
174. 174. Etkind PR, Qiu L, Lumb K. Dietary fat: Gene expression and mammary tumorigenesis. Nutr Cancer 1995;24:3-21.
175. 175. Karmali RA, Chao CC, Basu A, Modak M. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rat. Anticancer Res 1989; 9:1169-1174.
176. 176. Samples BL, Pool GL, Lumb RH. Omega-3 fatty acids induce apoptosis in HL-60 cells. FASEB J 1995; 9:1311.